A Phase I Study of AdV-tk + Prodrug Therapy in Combination With Radiation Therapy for Pediatric Brain Tumors

NCT00634231 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

8

Enrollment

INDUSTRY

Sponsor class

Conditions

Malignant Glioma
Recurrent Ependymoma

Interventions

BIOLOGICAL: AdV-tk
DRUG: valacyclovir
RADIATION: Radiation

Sponsor

Candel Therapeutics, Inc.

Collaborators

[object Object]